These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1174692)

  • 1. Iron metabolism, sickle cell disease, and response to cyanate.
    Peterson CM; Graziano JH; de Ciutiis A; Grady RW; Cerami A; Worwood M; Jacobs A
    Blood; 1975 Oct; 46(4):583-90. PubMed ID: 1174692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron stores in adults with sickle cell anemia.
    Rao KR; Patel AR; McGinnis P; Patel MK
    J Lab Clin Med; 1984 May; 103(5):792-7. PubMed ID: 6715957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron burden in sickle cell anemia.
    O'Brien RT
    J Pediatr; 1978 Apr; 92(4):579-82. PubMed ID: 633016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
    Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoradiometric serum ferritin concentration compared with stainable bone-marrow iron as indices to iron stores.
    Forman DT; Vye MV
    Clin Chem; 1980 Jan; 26(1):145-7. PubMed ID: 7356550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium cyanate as a potential treatment for sickle-cell disease.
    Gillette PN; Peterson CM; Lu YS; Cerami A
    N Engl J Med; 1974 Mar; 290(12):654-60. PubMed ID: 4813727
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic-therapeutic ratio of sodium cyanate.
    Charache S; Duffy TP; Jander N; Scott JC; Bedine M; Morrell R
    Arch Intern Med; 1975 Aug; 135(8):1043-7. PubMed ID: 1156065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of sickle cell disease: an approach with sodium cyanate.
    Peterson CM; Cerami A
    Semin Hematol; 1974 Oct; 11(4):569-76. PubMed ID: 4213637
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of sodium cyanate in patients with sickle cell disease and the lack of inhibition in vitro of globin synthesis at in vivo concentrations of cyanate.
    Nigen AM; Manning JM; Peterson CM; White JM
    J Pharmacol Exp Ther; 1975 Nov; 195(2):333-9. PubMed ID: 1185602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma ferritin level as a reliable index of body iron stores following intravenous iron dextran.
    Jacobs P; Dommisse J
    J Med; 1982; 13(4):309-21. PubMed ID: 6957530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron studies in pregnant and non-pregnant women with haemoglobin SS or SC disease.
    Oluboyede OA
    Br J Obstet Gynaecol; 1980 Nov; 87(11):989-96. PubMed ID: 7437371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis.
    Bell JD; Kincaid WR; Morgan RG; Bunce H; Alperin JB; Sarles HE; Remmers AR
    Kidney Int; 1980 Feb; 17(2):237-41. PubMed ID: 7382271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ferritin and bone marrow iron stores. I. Correlation with absence of iron in biopsy specimens.
    Krause JR; Stolc V
    Am J Clin Pathol; 1979 Nov; 72(5):817-20. PubMed ID: 506995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin levels in anemia of rheumatoid arthritis.
    Smith RJ; Davis P; Thomson AB; Wadsworth LD; Fackre P
    J Rheumatol; 1977; 4(4):389-92. PubMed ID: 604478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism.
    Porter JB; Huehns ER
    Acta Haematol; 1987; 78(2-3):198-205. PubMed ID: 3120472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferiprone as an oral iron chelator in sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
    Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deposition in cranial bone marrow with sickle cell disease: MR assessment using a fat suppression technique.
    Kaneko K; Humbert JH; Kogutt MS; Robinson AE
    Pediatr Radiol; 1993; 23(6):435-8. PubMed ID: 8255645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.